In last trading session, Spruce Biosciences Inc (NASDAQ:SPRB) saw 1.31 million shares changing hands with its beta currently measuring 2.38. Company’s recent per share price level of $0.43 trading at $0.02 or 3.43% at ring of the bell on the day assigns it a market valuation of $17.56M. That closing price of SPRB’s stock is at a discount of -1283.72% from its 52-week high price of $5.95 and is indicating a premium of 20.93% from its 52-week low price of $0.34.
For Spruce Biosciences Inc (SPRB), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 3.00. Splitting up the data highlights that, out of 5 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 5 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.2 in the current quarter.
Spruce Biosciences Inc (NASDAQ:SPRB) trade information
Upright in the green during last session for gaining 3.43%, in the last five days SPRB remained trading in the green while hitting it’s week-highest on Thursday, 02/20/25 when the stock touched $0.43 price level, adding 1.29% to its value on the day. Spruce Biosciences Inc’s shares saw a change of 1.21% in year-to-date performance and have moved 3.58% in past 5-day. Spruce Biosciences Inc (NASDAQ:SPRB) showed a performance of 13.72% in past 30-days.
Spruce Biosciences Inc (SPRB) estimates and forecasts
This year revenue growth is estimated to fall -49.52% from the last financial year’s standing.
5 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 885k for the same. And 4 analysts are in estimates of company making revenue of 500k in the next quarter. Company posted 2.89M and 2M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -22.95% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 24.68% while estimates for its earnings growth in next 5 years are of 20.77%.
Spruce Biosciences Inc (NASDAQ:SPRB)’s Major holders
RIVERVEST VENTURE MANAGEMENT LLC is the top institutional holder at SPRB for having 2.94 million shares of worth $1.52 million. And as of 2024-06-30, it was holding 7.1449 of the company’s outstanding shares.
The second largest institutional holder is CARLYLE GROUP INC., which was holding about 2.9 million shares on 2024-06-30. The number of shares represents firm’s hold over 7.0481 of outstanding shares, having a total worth of $1.52 million.
